Dk. Sommers et al., INFLUENCE OF ANTAGONISM AT 5-HT1A AUTORECEPTORS ON DEXFENFLURAMINE-INDUCED PROLACTIN-RELEASE DURING TREATMENT WITH FLUOXETINE, Medical science research, 26(9), 1998, pp. 585-586
We have conducted a placebo-controlled study to compare the effects of
fluoxetine, with or without the 5-hydroxytryptamine(1A) (5-HT1A) anta
gonist pindolol, on dexfenfluramine-induced prolactin release and thus
on 5-HT turnover. 20 healthy male Caucasians participated. Following
a single-blind, random design, on each experimental day each volunteer
received 60 mg dexfenfluramine taken with 250 ml water at zero time.
Two regimens were followed: (1) 20 mg fluoxetine plus a placebo tablet
daily for 14 days; (2) 20 mg fluoxetine plus 20 mg pindolol daily for
14 days. Although some of the post-dexfenfluramine pro lactin levels
were lower after 14 days with both regimens, there were no significant
differences in prolactin response between the two regimens. These res
ults do not validate the suggestion that blockade of 5-MT1A autorecept
ors may lead to a reduction in feedback inhibition of 5-HT release fro
m neuronal terminals. However, both fluoxetine and pindolol can interf
ere with the release of either serotonin or prolactin. Med Sci Res 26:
585-586 (C) 1998 Lippincott Williams & Wilkins.